aspirin has been researched along with dmp 728 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altajar, B; Alturk, N; Atac, B; Burns, B; Frishman, WH; Lerrick, K | 1 |
1 review(s) available for aspirin and dmp 728
| Article | Year |
|---|---|
Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor.
Topics: Abciximab; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Disintegrins; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Mesylates; Molecular Sequence Data; Myocardial Ischemia; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1995 |